Soluble egg antigens of Schistosoma japonicum induce senescence in activated hepatic stellate cells by activation of the STAT3/p53/p21 pathway

被引:0
作者
Jinling Chen
Jing Pan
Jianxin Wang
Ke Song
Dandan Zhu
Caiqun Huang
Yinong Duan
机构
[1] School of Medicine,Department of Pathogen Biology
[2] Nantong University,undefined
[3] Laboratory Medicine Center,undefined
[4] Affiliated Hospital of Nantong University,undefined
[5] Orthopedics and Traumatology Center of PLA,undefined
[6] The 153rd Central Hospital of People's Liberation Army,undefined
来源
Scientific Reports | / 6卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Liver fibrosis is characterized by the activation of hepatic stellate cells (HSCs). Recent findings suggest that senescence of activated HSCs might limit the development of liver fibrosis. Based on previously observed anti-fibrotic effects of soluble egg antigens from Schistosoma japonicum in vitro, we hypothesized that SEA might play a crucial role in alleviating liver fibrosis through promoting senescence of activated HSCs. We show here that SEA inhibited expression of α-SMA and pro-collagen I and promoted senescence of activated HSCs in vitro. In addition, SEA induced an increased expression of P-p53 and p21. Knockdown of p53 inhibited the expression of p21 and failed to induce senescence of activated-HSCs. Phosphorylated STAT3 was elevated upon SEA stimulation, while loss of STAT3 decreased the level of p53 and senescence of HSCs. Results from immunoprecipitation analysis demonstrated that SOCS3 might be involved in the SEA-induced senescence in HSCs through its interaction with p53. This study demonstrates the potential capacity of SEA in restricting liver fibrosis through promoting senescence in HSCs. Furthermore, a novel STAT3-p53-p21 pathway might participate in the observed SEA-mediated senescence of HSCs. Our results suggest that SEA might carry potential therapeutic effects of restraining liver fibrosis through promoting senescence.
引用
收藏
相关论文
共 79 条
[1]  
Wang J(2014)Schistosoma japonicum soluble egg antigens facilitate hepatic stellate cell apoptosis by downregulating Akt expression and upregulating p53 and DR5 expression PLoS Negl Trop Dis 8 e3106-1159
[2]  
Kong X(2012)Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice Hepatology 56 1150-218
[3]  
Bataller R(2005)Liver fibrosis Journal of Clinical Investigation 115 209-2090
[4]  
Brenner DA(2013)Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts Molecular and cellular biology 33 2078-456
[5]  
Kim KH(2011)Pathogenesis of liver fibrosis Annu Rev Pathol 6 425-250
[6]  
Chen CC(2013)Clearance of activated stellate cells for hepatic fibrosis regression: molecular basis and translational potential Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 67 246-839
[7]  
Monzon RI(2008)Partial hepatectomy-induced regeneration accelerates reversion of liver fibrosis involving participation of hepatic stellate cells Experimental biology and medicine (Maywood, N.J.) 233 827-667
[8]  
Lau LF(2008)Senescence of Activated Stellate Cells Limits Liver Fibrosis Cell 134 657-1140
[9]  
Hernandez-Gea V(2015)p53 protein-mediated up-regulation of MAP kinase phosphatase 3 (MKP-3) contributes to the establishment of the cellular senescent phenotype through dephosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2) The Journal of biological chemistry 290 1129-1031
[10]  
Friedman SL(2008)Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network Cell 133 1019-663